MS2DECIDE: Harnessing the complementarity of mass spectrometry annotation tools for prioritizing novel natural products.
- DOI
- 10.1016/bs.mie.2026.03.002
- Published
- 2026
- Container
- Methods in enzymology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/bs.mie.2026.03.002,
title = {MS2DECIDE: Harnessing the complementarity of mass spectrometry annotation tools for prioritizing novel natural products.},
author = {Mejri Y and Cailloux O and Le Pogam P and Öztürk-Escoffier M and Beniddir MA},
year = {2026},
journal = {Methods in enzymology},
doi = {10.1016/bs.mie.2026.03.002},
url = {https://doi.org/10.1016/bs.mie.2026.03.002}
}RIS
TY - JOUR TI - MS2DECIDE: Harnessing the complementarity of mass spectrometry annotation tools for prioritizing novel natural products. AU - Mejri Y AU - Cailloux O AU - Le Pogam P AU - Öztürk-Escoffier M AU - Beniddir MA PY - 2026 JO - Methods in enzymology DO - 10.1016/bs.mie.2026.03.002 UR - https://doi.org/10.1016/bs.mie.2026.03.002 ER -
APA
Y, M., O, C., P, L. P., M, Ö., & MA, B. (2026). MS2DECIDE: Harnessing the complementarity of mass spectrometry annotation tools for prioritizing novel natural products.. Methods in enzymology. https://doi.org/10.1016/bs.mie.2026.03.002
Source records
- pubmed · retrieved 2026-09-25T02:15:59.665Z